Dalian BIO-CHEM Company Limited (SHA:603360)
China · Delayed Price · Currency is CNY 13.45
-0.14 (-1.03%)
Aug 14, 2026, 3:00 PM CST
Dalian BIO-CHEM Company Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,302 | 22,582 | 10,998 | 3,732 | 4,451 | 3,334 | |
Market Cap Growth | -40.13% | 105.32% | 194.70% | -16.15% | 33.48% | -16.39% |
Enterprise Value | 10,143 | 23,522 | 10,736 | 3,361 | 4,263 | 3,506 |
Last Close Price | 13.45 | 32.22 | 15.55 | 5.09 | 5.73 | 4.25 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 53.49 | 107.65 | 28.07 | 11.37 | 11.06 | 13.31 |
Forward PE | - | 88.27 | 30.48 | 10.46 | 11.95 | 13.57 |
PS Ratio | 6.21 | 13.10 | 8.65 | 3.50 | 3.54 | 3.31 |
PB Ratio | 4.53 | 11.08 | 4.60 | 2.28 | 3.05 | 3.18 |
P/TBV Ratio | 8.78 | 21.85 | 7.50 | 2.34 | 3.14 | 3.48 |
P/FCF Ratio | 17.27 | 44.28 | 124.88 | 11.58 | 12.88 | - |
P/OCF Ratio | 16.13 | 41.31 | 67.48 | 9.58 | 9.27 | 23.48 |
PEG Ratio | - | 0.46 | 0.46 | 0.46 | 0.52 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.77 | 13.64 | 8.45 | 3.15 | 3.39 | 3.49 |
EV/EBITDA Ratio | 24.62 | 50.77 | 24.05 | 7.64 | 8.25 | 9.93 |
EV/EBIT Ratio | 32.95 | 63.49 | 28.43 | 8.93 | 9.57 | 11.50 |
EV/FCF Ratio | 18.83 | 46.12 | 121.91 | 10.43 | 12.34 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.70 | 0.66 | 0.24 | 0.09 | 0.09 | 0.32 |
Debt / EBITDA Ratio | 3.50 | 2.87 | 1.27 | 0.34 | 0.25 | 0.96 |
Debt / FCF Ratio | 2.68 | 2.64 | 6.45 | 0.47 | 0.37 | - |
Net Debt / Equity Ratio | 0.10 | 0.06 | -0.06 | -0.27 | -0.20 | 0.04 |
Net Debt / EBITDA Ratio | 0.49 | 0.24 | -0.34 | -1.02 | -0.56 | 0.13 |
Net Debt / FCF Ratio | 0.37 | 0.22 | -1.74 | -1.39 | -0.84 | -0.89 |
Asset Turnover | 0.38 | 0.45 | 0.45 | 0.58 | 0.73 | 0.65 |
Inventory Turnover | 0.96 | 1.11 | 1.26 | 2.69 | 3.35 | 3.80 |
Quick Ratio | 1.62 | 1.64 | 1.10 | 3.67 | 3.40 | 0.91 |
Current Ratio | 2.86 | 2.87 | 2.25 | 4.70 | 4.36 | 1.36 |
Return on Equity (ROE) | 10.95% | 13.87% | 19.74% | 21.20% | 32.06% | 24.58% |
Return on Assets (ROA) | 4.87% | 6.08% | 8.34% | 12.73% | 16.26% | 12.29% |
Return on Invested Capital (ROIC) | 12.16% | 14.67% | 19.47% | 27.15% | 34.31% | 25.66% |
Return on Capital Employed (ROCE) | 10.20% | 12.40% | 14.70% | 22.50% | 29.40% | 26.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.85% | 0.93% | 3.56% | 8.80% | 9.04% | 7.51% |
FCF Yield | 5.79% | 2.26% | 0.80% | 8.64% | 7.77% | -1.49% |
Dividend Yield | 4.46% | - | 3.86% | 6.02% | 5.09% | - |
Payout Ratio | 193.26% | 158.05% | 57.08% | 63.00% | 1.61% | 63.48% |
Buyback Yield / Dilution | 1.57% | 0.05% | -0.43% | -0.64% | 0.30% | 3.01% |
Total Shareholder Return | 6.03% | 0.05% | 3.43% | 5.38% | 5.39% | 3.01% |